Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2014
10/30/2014US20140322304 Compositions and methods relating to proliferative diseases
10/30/2014US20140322303 Liposomal curcumin for treatment of diseases
10/30/2014US20140322302 Therapeutic peptides
10/30/2014US20140322292 Insulin-mimetics as therapeutic adjuncts for bone regeneration
10/30/2014US20140322274 Therapeutic Agents
10/30/2014US20140322264 Therapeutic vaccination against active tuberculosis
10/30/2014US20140322247 Cell proliferation inhibitors and conjugates thereof
10/30/2014US20140322242 Materials and methods for the prevention and treatment of cancer
10/30/2014US20140322229 Heterocyclic amides compounds which are hdac6 inhibitors and used as anti-tumoral agents
10/30/2014US20140322227 Peptides for treatment of bone deficiency and autoimmune disorders
10/30/2014US20140322226 Acth for treatment of acute respiratory distress syndrome
10/30/2014US20140322225 Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
10/30/2014US20140322221 Multivalent antibodies and uses therefor
10/30/2014US20140322220 Anti-FGFR2 Antibodies and Uses Thereof
10/30/2014US20140322208 Treatment of hematologic malignancies with an anti-cxcr4 antibody
10/30/2014US20140322205 Rtef-1 variants and the use thereof for inhibition of angiogenesis
10/30/2014US20140322202 TREATMENT WITH ANTI ErbB2 ANTIBODIES
10/30/2014US20140322200 Combination therapy of an afucosylated cd20 antibody with an anti-vegf antibody
10/30/2014US20140322198 Composition comprising vicenin-2 having a beneficial effect on neurological and/or cognitive function
10/30/2014US20140322197 Methods for treatment of hip and groin pain associated with femoroacetabular impingement (fai)
10/30/2014US20140322195 Factor IXA Inhibitors
10/30/2014US20140322190 Pharmaceutical Compositions and Methods for Digesting Atherosclerotic Plaques
10/30/2014US20140322189 Composition based on ubidecarenone
10/30/2014US20140322175 Use Of Umbilical Cord Blood To Treat Individuals Having A Disease, Disorder Or Condition
10/30/2014US20140322165 Inhibitors of hepatitis c virus polymerase
10/30/2014US20140322163 Neutralizing antibodies to hiv-1 and their use
10/30/2014US20140322157 Bi-Functional Co-Polymer Use for Ophthalmic and Other Topical and Local Applications
10/30/2014US20140322149 Compound useful for treating cellulite
10/30/2014US20140322134 Treatment and Imaging Methods Using Antibodies to Aminophospholipids
10/30/2014US20140322131 Methods and Agents for the Diagnosis and Treatment of Hepatocellular Carcinoma
10/30/2014US20140322130 Specific binding proteins and uses thereof
10/30/2014US20140322129 Anti-b7-h4 antibodies and immunoconjugates
10/30/2014US20140322128 Materials and Methods Useful to Induce Cell Death via Methuosis
10/30/2014US20140319030 Citrate-Based Dialysate Chemical Formulations
10/28/2014US8871925 Compositions of novel carbohydrate drug for treatment of human diseases
10/28/2014US8871915 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof
10/28/2014US8871911 Compositions and methods for the diagnosis and treatment of tumor
10/28/2014US8871818 Gastrointestinal absorption enhancer mediated by proton-coupled transporter and its preparing method
10/28/2014US8871802 Naphthoquinones for disease therapies
10/28/2014US8871792 Neprilysin inhibitors
10/28/2014US8871789 Method of preventing or treating viral infection
10/28/2014US8871781 Methods and compositions for treating a subject for a lymphatic malformation
10/28/2014US8871780 Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, method of making and use thereof
10/28/2014US8871774 Inhibitors of influenza viruses replication
10/28/2014US8871758 Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
10/28/2014US8871754 Compounds and compositions for the treatment of parasitic diseases
10/28/2014US8871750 Use of aromatase inhibitors for endometrial thinning in preparation for surgical procedures on the endometrial cavity and uterus
10/28/2014US8871748 Retinal cyclodextrin acetals and hemiacetals for treating skin complexion disorder
10/28/2014US8871742 Composition and method for treating connective tissue damage
10/28/2014US8871740 Use of polysaccharides for treating stress and anxiety
10/28/2014US8871737 Substituted nucleotide analogs
10/28/2014US8871732 Immunostimulatory sequence oligonucleotides and methods of using the same
10/28/2014US8871725 Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs
10/28/2014US8871718 Transglutaminase inhibitors and methods of use thereof
10/28/2014US8871715 Use of selenium compounds, especially selenium yeasts for altering cognitive function
10/28/2014US8871506 Methods for treating cardio pulmonary diseases with NO group compounds
10/28/2014US8871452 Methods for treatment of cardiovascular disease
10/28/2014US8871436 Immunostimulatory oligonucleotides and uses thereof
10/28/2014US8871281 Treatment of oral pharyngeal dysphagia
10/28/2014US8871264 Immediate release tablet formulations
10/28/2014US8871253 Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt
10/28/2014US8871246 Local administration of gallium compositions to treat pain
10/28/2014US8871241 Injectable sustained release delivery devices
10/28/2014US8871228 Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids
10/28/2014US8871215 Flagellin related polypeptides and uses thereof
10/28/2014US8871210 Chemokine receptor antagonists and use thereof
10/28/2014US8871208 11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors and uses thereof
10/28/2014US8871199 Compositions and methods to promote implantation and engrafment of stem cells
10/28/2014US8871191 Use of IL-15 preparations to treat lymphopenia
10/23/2014US20140316005 Compositions for improved oxidative status in companion animals
10/23/2014US20140315973 Parp-1 inhibitors
10/23/2014US20140315958 4-[4-(amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrate
10/23/2014US20140315953 Method and composition for treating migraines
10/23/2014US20140315940 Morphinan compounds
10/23/2014US20140315938 Compositions for controlling food intake and uses therefor
10/23/2014US20140315936 Apricitabine and pi combination therapy
10/23/2014US20140315929 Hsp90 combination therapy
10/23/2014US20140315928 Substituted amide compounds
10/23/2014US20140315927 Inhibitors of HIV Replication
10/23/2014US20140315922 Method of treating parkinson's disease with a diarylmethylpiperazine compounds exhibiting delta opioid receptor agonist activity
10/23/2014US20140315912 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
10/23/2014US20140315911 Dihydropteridinones
10/23/2014US20140315894 Anti-cancer compounds targeting ral gtpases and methods of using the same
10/23/2014US20140315892 Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disorders
10/23/2014US20140315886 Quinazolines as therapeutic compounds and related methods of use
10/23/2014US20140315876 Beta-lactamase inhibitors
10/23/2014US20140315868 Organic compounds
10/23/2014US20140315865 Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
10/23/2014US20140315852 Nucleoside phosphoramidate prodrugs
10/23/2014US20140315850 2',3'-Dideoxy-2'-alpha-Fluoro-2'-beta-C-Methylnucleosides and Prodrugs Thereof
10/23/2014US20140315845 Hsp90 inhibitors with modified toxicity
10/23/2014US20140315832 Pharmaceutical composition, methods for treating and uses thereof
10/23/2014US20140315821 Treatments involving eslicarbazepine acetate or eslicarbazepine
10/23/2014US20140315810 Agent for the treatment of alopecia
10/23/2014US20140315807 Treatment and Prevention of Bone Loss Using Resolvins
10/23/2014US20140315794 Antiparisitic dihydroazole compounds and compositions comprising same
10/23/2014US20140315790 Aminothiazoles and their uses
10/23/2014US20140314890 Combination anti-cancer therapy
10/23/2014US20140314888 Anti-inflammatory composition comprising malvidin -3 - o - beta-glucoside and a propolis extract
10/23/2014US20140314875 Composition and method for improving vascular health
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 1151